Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/10/21 → 3/10/25 |
Funding
- N2 Pharmaceuticals: £11,500.00
Industry Contribution - New strategies to promote endogenous cardiac neovasculogenesis after myocardial infarction
- Brittan, Mairi (Principal Investigator)
- Baker, Andrew (Co-investigator)
- Hadoke, Patrick (Co-investigator)